IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Takeda Pharmaceutical Co LTD

Q3 2024 Holdings

Filed 2025-02-13 | 12 holdings | $38.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
HilleVax, Inc.COM43157M102$11.8M6,724,00031.2%
Wave Life Sciences Ltd.(WVE)SHSY95308105$11.0M1,346,89229.1%
Ovid Therapeutics Inc.(OVID)COM690469101$8.9M7,531,99623.4%
Shattuck Labs, Inc.(STTK)COM82024L103$1.8M515,6194.7%
Equillium, Inc.(EQ)COM29446K106$1.5M1,824,9774.0%
Xilio Therapeutics, Inc.(XLO)COM98422T100$1.2M1,475,1213.1%
American Well Corp(AMWL)COM CL A NEW03044L204$736.9K77,7331.9%
Turnstone Biologics Corp.COM90042W100$499.0K895,8241.3%
Rani Therapeutics Holdings, Inc.(RANI)COM CL A753018100$438.9K203,1901.2%
Standard Biotools Inc.(LAB)COM34385P108$31.9K16,5150.1%